首页> 外国专利> Novel peptides, directed antibodies against these peptides, application by way of medicinal products, pharmaceutical compositions containing them and diagnostic kits.

Novel peptides, directed antibodies against these peptides, application by way of medicinal products, pharmaceutical compositions containing them and diagnostic kits.

机译:新型肽,针对这些肽的定向抗体,通过医药产品的应用,包含它们的药物组合物和诊断试剂盒。

摘要

Peptide monomers (I), recognised by a humoral or cellular immune response and producing a auto-immune reaction in subjects infected with HIV-1 or -2 are of formulae: SLWDQ (1) SLWDQSLK (51) DIISLWDQSLD (3) HEDIISLWDQSLKPCVK (46) VEINCTRR1R2N (22) FR3CNST (24) YVGSR4LEI (27) PLTEEA (29) QGQWTR5Q (30) RR6GVETTTPS (48) EALKYW (34) CNSTV (26) EETAGVVSTN (50) VVSTNLIRNG (14) VEINCTR (37) INCTR (52); R1-R2 = T-Q or P-N; R3 = Y or F; R4 = D or N; R5 = Y or Q; R6 = S or A. Opt. (I) also have 1-5 amino acids more at C and/or N termini and also included are multimers having 2-6 (I) units in a linear chain.
机译:被体液或细胞免疫应答识别并在感染HIV-1或-2的受试者中产生自身免疫反应的肽单体(I)的分子式为:SLWDQ(1)SLWDQSLK(51)DIISLWDQSLD(3)HEDIISLWDQSLKPCVK(46 )VEINCTRR1R2N(22)FR3CNST(24)YVGSR4LEI(27)PLTEEA(29)QGQWTR5Q(30)RR6GVETTTPS(48)EALKYW(34)CNSTV(26)EETAGVVSTN(50)VVSTNLIRNG(14)VEINCTR(37); R1-R2 = T-Q或P-N; R3 = Y或F; R4 = D或N; R5 = Y或Q; R6 = S或A。 (I)在C和/或N末端还具有1-5个氨基酸,并且还包括在直链中具有2-6(I)个单元的多聚体。

著录项

  • 公开/公告号FR2694560B1

    专利类型

  • 公开/公告日1995-06-30

    原文格式PDF

  • 申请/专利权人 ZAGURY JEAN FRANCOIS;

    申请/专利号FR19920009884

  • 发明设计人 ZAGURY JEAN-FRANCOIS;

    申请日1992-08-10

  • 分类号C07K7/00;A61K37/02;A61K39/21;A61K39/44;C07K13/00;C12P21/08;G01N33/569;

  • 国家 FR

  • 入库时间 2022-08-22 04:07:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号